drugset
drugset / Trial / NCT01082276

Rifampin Drug-Drug Interaction Study With Lurasidone HCl

NCT01082276 ↗

Phase 1 Completed 20 enrolled Sumitomo Pharma America, Inc.
RandomizedSingle-groupOpen-label

Summary

The effect of rifampin on the pharmacokinetics of lurasidone

Timeline

Start
2008-08
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Lurasidone Small molecule 40 mg Oral

Indications

No indication recorded.